HiRO - Harvest Integrated Research Organization Revenue and Competitors
Employee Data
- HiRO - Harvest Integrated Research Organization has 82 Employees.
- HiRO - Harvest Integrated Research Organization grew their employee count by 41% last year.
HiRO - Harvest Integrated Research Organization's People
Name | Title | Email/Phone |
---|
HiRO - Harvest Integrated Research Organization Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $8.5M | 55 | -21% | N/A | N/A |
#2 | $0.2M | 1 | 0% | N/A | N/A |
#3 | $8.5M | 55 | -29% | N/A | N/A |
#4 | $108.5M | 500 | 2% | N/A | N/A |
#5 | $0.8M | 5 | 0% | N/A | N/A |
#6 | $0.6M | 4 | 0% | N/A | N/A |
#7 | $14.7M | 68 | -23% | $206.4M | N/A |
#8 | $492.2M | 1503 | -15% | $568M | N/A |
#9 | $1.1M | 7 | -42% | N/A | N/A |
#10 | $4.5M | 29 | 0% | N/A | N/A |
What Is HiRO - Harvest Integrated Research Organization?
Harvest Integrated Research Organization (HiRO) is a globally oriented, innovative clinical research organization (CRO). With global operations and integrated capabilities, HiRO provides a full range of cross-border solutions and services to its clients, including early pre-clinical strategic planning, clinical trial design, regulatory affairs, pharmacovigilance, statistics, data management, end-to-end project management, and clinical and medical monitoring services.\n\nAs an emerging global CRO, HiRO strives to become a market-leading, integrated global clinical research organization that works collaboratively with biotech and pharmaceutical companies to bring new products from the laboratory to the market, providing more effective solutions for patients worldwide.
keywords:N/AN/A
Total Funding
82
Number of Employees
N/A
Revenue (est)
41%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $7.5M | 82 | 12% | N/A |
#2 | $22.4M | 83 | 0% | $4.8M |
#3 | $12.3M | 85 | -19% | $20.6M |
#4 | $12.5M | 86 | 6% | N/A |
#5 | $12.8M | 88 | 10% | N/A |